Preliminary characterisation of the promoter of the human p22phox gene:: identification of a new polymorphism associated with hypertension

被引:78
作者
Moreno, MU
San José, G
Orbe, J
Páramo, JA
Beloqui, O
Díez, J
Zalba, G
机构
[1] Univ Navarra, Div Cardiovasc Pathophysiol, Ctr Appl Med Res, Sch Med, Pamplona 31008, Spain
[2] Univ Navarra, Dept Hematol, Univ Clin, E-31080 Pamplona, Spain
[3] Univ Navarra, Dept Internal Med, Univ Clin, E-31080 Pamplona, Spain
[4] Univ Navarra, Dept Cardiol & Cardiovasc Surg, Univ Clin, E-31080 Pamplona, Spain
来源
FEBS LETTERS | 2003年 / 542卷 / 1-3期
关键词
hypertension; NAD(P)H oxidase; polymorphism; promoter;
D O I
10.1016/S0014-5793(03)00331-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The P22(phox) subunit is an essential protein in the activation of NAD(P)H oxidase. Here we report the preliminary characterisation of the human p22(phox) gene promoter. The p22(phox) promoter contains TATA and CCAC boxes and Sp1, gamma-interferon and nuclear factor kappaB sites. We screened for mutations in the P22(phox) promoter and identified a new polymorphism, localised at position -930 from the ATG codon, which was associated with hypertension. Mutagenesis experiments showed that the G allele had higher promoter activity than the A allele. These results suggest that the -930(A/G) polymorphism in the p22(phox) promoter may be a novel genetic marker associated with hypertension. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 23 条
  • [1] Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production
    Bouloumie, A
    Bauersachs, J
    Linz, W
    Scholkens, BA
    Wiemer, G
    Fleming, I
    Busse, R
    [J]. HYPERTENSION, 1997, 30 (04) : 934 - 941
  • [2] ENZYMATIC MECHANISMS OF SUPEROXIDE PRODUCTION
    CROSS, AR
    JONES, OTG
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1057 (03) : 281 - 298
  • [3] DEBOER M, 1992, AM J HUM GENET, V51, P1127
  • [4] Assembly of the phagocyte NADPH oxidase: Molecular interaction of oxidase proteins
    DeLeo, FR
    Quinn, MT
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (06) : 677 - 691
  • [5] HUMAN NEUTROPHIL CYTOCHROME-B LIGHT CHAIN (P22-PHOX) - GENE STRUCTURE, CHROMOSOMAL LOCATION, AND MUTATIONS IN CYTOCHROME-NEGATIVE AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS-DISEASE
    DINAUER, MC
    PIERCE, EA
    BRUNS, GAP
    CURNUTTE, JT
    ORKIN, SH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) : 1729 - 1737
  • [6] Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats
    Fortuño, A
    Muñiz, P
    Ravassa, S
    Rodriguez, JA
    Fortuño, MA
    Zalba, G
    Díez, J
    [J]. HYPERTENSION, 1999, 34 (01) : 138 - 143
  • [7] p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
    Fukui, T
    Ishizaka, N
    Rajagopalan, S
    Lauren, JB
    Capers, Q
    Taylor, WR
    Harrison, DG
    deLeon, H
    Wilcox, JN
    Griendling, KK
    [J]. CIRCULATION RESEARCH, 1997, 80 (01) : 45 - 51
  • [8] NAD(P)H oxidase - Role in cardiovascular biology and disease
    Griendling, KK
    Sorescu, D
    Ushio-Fukai, M
    [J]. CIRCULATION RESEARCH, 2000, 86 (05) : 494 - 501
  • [9] IDENTIFICATION OF ALLELE-SPECIFIC P22-PHOX MUTATIONS IN A COMPOUND HETEROZYGOUS PATIENT WITH CHRONIC GRANULOMATOUS-DISEASE BY MISMATCH PCR AND RESTRICTION ENZYME ANALYSIS
    HOSSLE, JP
    DEBOER, M
    SEGER, RA
    ROOS, D
    [J]. HUMAN GENETICS, 1994, 93 (04) : 437 - 442
  • [10] Interactions between the components of the human NADPH oxidase: Intrigues in the phox family
    Leusen, JHW
    Verhoeven, AJ
    Roos, D
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (05): : 461 - 476